Literature DB >> 20162293

Separation of positional CPP isomers by chiral HPLC-DAD of seized tablets.

Jennifer Schürenkamp1, Justus Beike, Heidi Pfeiffer, Helga Köhler.   

Abstract

Meta-chlorophenylpiperazine, one of the synthetic piperazine-derived designer drugs, is to date controlled as an illicit substance in five European member states. Depending on the position of the chlorine atom, different positional isomers of CPP (ortho-, meta- and para-) are possible. Therefore, there is a need to develop an analytical method for the separation and identification of the three 1-chlorophenylpiperazines in tablets containing CPP. In this work, the position isomers o-, m- and p-CPP were separated by liquid chromatography (HPLC) on a reversed-phase chiral column. Different mobile phase compositions and pH ranges were systematically studied to find optimum chromatographic conditions. Best results were achieved with isocratic mobile phase of triethyl amine buffer and methanol (V/V = 70/30) at pH 9 with a flow rate of 0.8 ml/min. The method was validated in terms of selectivity, linearity, limit of detection and quantification and precision. At last, the developed method was successfully applied on seized ecstasy tablets.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20162293     DOI: 10.1007/s00414-010-0422-z

Source DB:  PubMed          Journal:  Int J Legal Med        ISSN: 0937-9827            Impact factor:   2.686


  20 in total

1.  Analysis of "Ecstasy" by capillary electrophoresis.

Authors:  M Frost; H Köhler; G Blaschke
Journal:  Int J Legal Med       Date:  1996       Impact factor: 2.686

2.  The subjective effects of MDMA and mCPP in moderate MDMA users.

Authors:  M E Tancer; C E Johanson
Journal:  Drug Alcohol Depend       Date:  2001-12-01       Impact factor: 4.492

3.  An announced suicide with ecstasy.

Authors:  Kathrin Libiseller; Marion Pavlic; Petra Grubwieser; Walter Rabl
Journal:  Int J Legal Med       Date:  2005-09-21       Impact factor: 2.686

4.  1-(m-chlorophenyl)piperazine (mCPP) interactions with neurotransmitter receptors in the human brain.

Authors:  A Hamik; S J Peroutka
Journal:  Biol Psychiatry       Date:  1989-03-01       Impact factor: 13.382

5.  Discriminative stimulus effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans trained to discriminate among d-amphetamine, meta-chlorophenylpiperazine and placebo.

Authors:  Chris-Ellyn Johanson; Marlyne Kilbey; Kristin Gatchalian; Manuel Tancer
Journal:  Drug Alcohol Depend       Date:  2005-06-21       Impact factor: 4.492

6.  Methylone and mCPP, two new drugs of abuse?

Authors:  M G Bossong; J P Van Dijk; R J M Niesink
Journal:  Addict Biol       Date:  2005-12       Impact factor: 4.280

7.  Serotonin syndrome after challenge with the 5-HT agonist meta-chlorophenylpiperazine.

Authors:  T Klaassen; K L Ho Pian; H G Westenberg; J A den Boer; H M van Praag
Journal:  Psychiatry Res       Date:  1998-07-13       Impact factor: 3.222

8.  Characterization of calixarene- and resorcinarene-bonded stationary phases. I. Hydrophobic interactions.

Authors:  Torsten Sokoliess; Janet Schönherr; Ulf Menyes; Ulrich Roth; Thomas Jira
Journal:  J Chromatogr A       Date:  2003-12-22       Impact factor: 4.759

9.  Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry.

Authors:  Frank T Peters; Simone Schaefer; Roland F Staack; Thomas Kraemer; Hans H Maurer
Journal:  J Mass Spectrom       Date:  2003-06       Impact factor: 1.982

10.  Postmortem distribution of 3,4-methylenedioxy-N,N-dimethyl-amphetamine (MDDM or MDDA) in a fatal MDMA overdose.

Authors:  Els A De Letter; Willy E Lambert; Marie-Paule L A Bouche; Jan A C M Cordonnier; Jan F Van Bocxlaer; Michel H A Piette
Journal:  Int J Legal Med       Date:  2006-04-25       Impact factor: 2.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.